← Leaderboards
Gregory Thomas Everson
University Of Colorado Denver
$3,261,547
Attributed
$3,261,547
Total exposure
19
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $401.2K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$3,261,547 · 19
By mechanism
M01$1,689,177 · 17
U01$1,060,351 · 1
N01$512,019 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Michael R. Narkewicz$249,387
- James F. Trotter$2,144,116
- James Burton$353,001
- Ronald J Sokol$193,385,254
Others in their field
Top investigators on “Hepatitis C”
- Constance Ann Benson · University Of California, San Diego$171,085,251
- Sharon A Nachman · Johns Hopkins University$116,441,543
- Peter B. Gilbert · Fred Hutchinson Cancer Center$94,107,997
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Richard Douglas Moore · Johns Hopkins University$59,121,971
- Charles R Rinaldo · University Of Pittsburgh At Pittsburgh$46,122,050
Research focus
Hepatitis CClinical ResearchHepatitis C VirusHuman SubjectHuman Therapy EvaluationInterferon AlphaChronic Disease /DisorderLiverLiver FunctionHepaticTransplantationImmunotherapyPreventRibavirinAntiviral AgentsAffectQuality Of LifeEnrollmentParticipantGrantResearch PersonnelCholatesFundingComputer Retrieval Of Information On Scientific Projects Database
Grant awards (37)
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)$172,344
U01 · FY2011 · DK · contact PI
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)$226,440
U01 · FY2010 · DK · contact PI
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)$33,482
U01 · FY2010 · DK · contact PI
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)$30,642
U01 · FY2010 · DK · contact PI
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)$217,054
U01 · FY2009 · DK · contact PI
Adult to adult living donor liver transplantation cohor*$380,389
U01 · FY2008 · DK · contact PI
HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C)$17,798
M01 · FY2008 · RR · contact PI
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HCV (QLFT)$1,542
M01 · FY2008 · RR · contact PI
A2ALL LADR PROTOCOL:PRE-TRNSPLNT TRTMNT TO PRVNT RCURRNCE OF HEPC AFT LVR TRNSPL$949
M01 · FY2008 · RR · contact PI
RESTORATION OF HEPATIC FUNCTION IN LIVING LIVER DONORS (ANCILLARY STUDY OF A2ALL$475
M01 · FY2008 · RR · contact PI
HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C)$151,479
M01 · FY2007 · RR · contact PI
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HCV (QLFT)$13,128
M01 · FY2007 · RR · contact PI
A2ALL LADR PROTOCOL:PRE-TRNSPLNT TRTMNT TO PRVNT RCURRNCE OF HEPC AFT LVR TRNSPL$8,079
M01 · FY2007 · RR · contact PI
RESTORATION OF HEPATIC FUNCTION IN LIVING LIVER DONORS (ANCILLARY STUDY OF A2ALL$4,039
M01 · FY2007 · RR · contact PI
HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C)$157,813
M01 · FY2006 · RR · contact PI
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HCV (QLFT)$6,807
M01 · FY2006 · RR · contact PI
A2ALL LADR PROTOCOL:PRE-TRNSPLNT TRTMNT TO PRVNT RCURRNCE OF HEPC AFT LVR TRNSPL$3,404
M01 · FY2006 · RR · contact PI
HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C)$186,433
M01 · FY2005 · RR
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HCV (QLFT)$38,602
M01 · FY2005 · RR
Hepatitis C Antiviral Treatment to Prevent Cirrhosis$222,038
M01 · FY2004 · RR
Quantitative Assessment of Hepatic Function$16,967
M01 · FY2004 · RR
INTRON A PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C$190,747
M01 · FY2002 · RR
TRIAL OF ALFACON-1 FOR CHRONIC HEPATITIS C VIRUS$190,747
M01 · FY2002 · RR
INTRON A PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C$190,747
M01 · FY2001 · RR
TRIAL OF ALFACON-1 FOR CHRONIC HEPATITIS C VIRUS$190,747
M01 · FY2001 · RR
TRIAL OF ALFACON-1 FOR CHRONIC HEPATITIS C VIRUS$0
M01 · FY2001 · RR
INTRON A PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C$0
M01 · FY2001 · RR
HEPATITIS C CLINICAL TRIAL-CLINICAL CENTERS$274,967
N01 · FY2000 · DK
HEPATITIS C CLINICAL TRIAL-CLINICAL CENTERS$237,052
N01 · FY2000 · DK
PHASE III--ALFERON N IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC HEPATITIS C$32,212
M01 · FY2000 · RR
PERCUTANEOUS HEPATOCYTE TRANSPLNTATN TIPS SHUNT MGMNT PTS W/ LIVER FAILURE$32,212
M01 · FY2000 · RR
INTRON A PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C$32,212
M01 · FY2000 · RR
INTRON A PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C$0
M01 · FY2000 · RR
PERCUTANEOUS HEPATOCYTE TRANSPLNTATN TIPS SHUNT MGMNT PTS W/ LIVER FAILURE$0
M01 · FY2000 · RR
PHASE III--ALFERON N IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC HEPATITIS C$0
M01 · FY2000 · RR
TRIAL OF ALFACON-1 FOR CHRONIC HEPATITIS C VIRUS$0
M01 · FY2000 · RR
TRIAL OF ALFACON-1 FOR CHRONIC HEPATITIS C VIRUS$0
M01 · FY2000 · RR